SS Innovations International (SSII) Convertible Debt (2023 - 2024)
SS Innovations International's (SSII) quarterly Convertible Debt came in at $58144.0 in Q3 2024, up 71.35% quarter-over-quarter from $33933.0 in Q4 2023.
SS Innovations International (SSII) Convertible Debt (2023 - 2024) Analysis & Trends
SS Innovations International has disclosed Convertible Debt across 2 years of filings, most recently posting $58144.0 for Q3 2024.
- Convertible Debt for Q3 2024 came in at $58144.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $58144.0 (changed N/A YoY), and the FY2023 annual result was $33933.0, changed N/A from the prior year.
- Convertible Debt came in at $58144.0 for Q3 2024 at SS Innovations International, up from $33933.0 in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $58144.0 in Q3 2024 to a low of $33933.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 58,144.00 |
| Dec 31, 2023 | 33,933.00 |